Pegasus Tech Ventures and CYBERDYNE launch a JPY 10 billion ($60 million（約96億円） U.S.) venture fund to invest in robotics and physical AI startups, aiming to blend human biology with AI and technology to address aging populations and workforce shortages.

What happened

Pegasus Tech Ventures, a San Jose-based venture capital firm, announced a new corporate venture capital fund with CYBERDYNE Inc., a Tsukuba, Japan-based robotics and cybernics company. Pegasus will serve as the general partner; CYBERDYNE as the sole limited partner. The fund will invest in startups developing robotics, physical AI, healthcare, automation, and intelligent systems, with a focus on advancing CYBERDYNE's vision for "human-cyber-physical space" (HCPS) cybernics.

Why it matters

CYBERDYNE brings deep expertise in cybernics—combining human biology and technology to enhance physical and cognitive functions—and has deployed its flagship Hybrid Assistive Limb (HAL) wearable device across medical, healthcare, and industrial sectors. The partnership lets CYBERDYNE access Pegasus's global network of startups, investors, and corporate partners to accelerate technology development and business collaboration on challenges like aging populations and workforce shortages.

What to watch

Pegasus manages more than 40 funds and over $2 billion（約3200億円） in assets, and has invested in more than 300 startups including SpaceX, OpenAI, and Anthropic. The new fund will leverage Pegasus's venture capital-as-a-service platform to connect CYBERDYNE with entrepreneurs and strategic opportunities from Silicon Valley and global innovation ecosystems.